Akito Yamaguchi

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Operating Times and Bleeding Complications in Percutaneous Nephrolithotomy: A Comparison of Tract Dilation Methods in 5537 Patients in the Clinical Research Office of the Endourological Society Percutaneous Nephrolithotomy Global Study

Akito Yamaguchi, Andreas Skolarikos, Niels‐Peter Buchholz et al. · Journal of Endourology · 2011 · 233 citations

Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer

Seiji Naito, Hirofumi Koga, Akito Yamaguchi et al. · The Journal of Urology · 2008 · 146 citations

Maintenance therapy with bacillus Calmette‐Guérin Connaught strain clearly prolongs recurrence‐free survival following transurethral resection of bladder tumour for non‐muscle‐invasive bladder cancer

Shiro Hinotsu, Hideyuki Akaza, Seiji Naito et al. · British Journal of Urology · 2010 · 102 citations

Laparoscopic Radical Nephroureterectomy: A Multicenter Analysis in Japan

Osamu Kamihira, Ryohei Hattori, Akito Yamaguchi et al. · European Urology · 2009 · 91 citations

Laparoscopic Radical Nephroureterectomy, Laparoscopy, Urology +5